GB201004304D0 - Biomarkers for prostate cancer - Google Patents
Biomarkers for prostate cancerInfo
- Publication number
- GB201004304D0 GB201004304D0 GBGB1004304.0A GB201004304A GB201004304D0 GB 201004304 D0 GB201004304 D0 GB 201004304D0 GB 201004304 A GB201004304 A GB 201004304A GB 201004304 D0 GB201004304 D0 GB 201004304D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biomarkers
- prostate cancer
- prostate
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1004304A GB2478734A (en) | 2010-03-15 | 2010-03-15 | Auto-antibody biomarkers of prostate cancer |
| PCT/GB2011/050489 WO2011114139A1 (en) | 2010-03-15 | 2011-03-11 | Auto-antigen biomarkers for prostate cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1004304A GB2478734A (en) | 2010-03-15 | 2010-03-15 | Auto-antibody biomarkers of prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201004304D0 true GB201004304D0 (en) | 2010-04-28 |
| GB2478734A GB2478734A (en) | 2011-09-21 |
Family
ID=42261619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1004304A Withdrawn GB2478734A (en) | 2010-03-15 | 2010-03-15 | Auto-antibody biomarkers of prostate cancer |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB2478734A (en) |
| WO (1) | WO2011114139A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113721031A (en) * | 2021-08-30 | 2021-11-30 | 河南中医药大学 | Serum-related autoantibody marker for auxiliary diagnosis of hashimoto thyroiditis and application thereof |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201017520D0 (en) * | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| SG10201908922UA (en) * | 2019-09-25 | 2021-04-29 | Sengenics Corp Pte Ltd | Identification of health status in the elderly using immunological biomarkers |
| CN119881317B (en) * | 2025-03-25 | 2025-07-04 | 德州学院 | Paper chip for simultaneously detecting multiple prostate cancer markers and preparation method and application thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1004304A (en) | 1963-08-20 | 1965-09-15 | Jeffrey Hulme | Manufacture of pottery |
| WO2001057198A2 (en) | 2000-01-31 | 2001-08-09 | Sense Proteomic Limited | Methods of generating protein expression arrays and the use thereof in rapid screening |
| JP2003522962A (en) | 2000-02-16 | 2003-07-29 | クァンタム・ドット・コーポレイション | Microarray method using semiconductor nanocrystals |
| JP2004509645A (en) | 2000-08-17 | 2004-04-02 | センス・プロテオミック・リミテッド | Method |
| US20090226915A1 (en) | 2001-01-24 | 2009-09-10 | Health Discovery Corporation | Methods for Screening, Predicting and Monitoring Prostate Cancer |
| SE0100595D0 (en) * | 2001-02-22 | 2001-02-22 | Lena Carlsson | Immunological detection of prostate diseases and prostatic-related diseases |
| GB0202018D0 (en) | 2002-01-29 | 2002-03-13 | Sense Proteomic Ltd | Tag and method |
| US20030224462A1 (en) * | 2002-06-04 | 2003-12-04 | Parsons George H. | Immunoassay for cancer |
| DE60315343T2 (en) | 2002-10-25 | 2008-04-17 | Sense Proteomic Ltd., Maidenhead | NOVEL USES OF BLE GENES PROTEINS AND ANTIBIOTICS FROM THE BLEOMYCIN FAMILY |
| US20080081339A1 (en) | 2006-10-03 | 2008-04-03 | The Brigham And Women's Hospital, Inc. | Tumor associated markers in the diagnosis of prostate cancer |
| WO2008061104A2 (en) * | 2006-11-13 | 2008-05-22 | Invitrogen Corporation | Methods and kits for detecting prostate cancer biomarkers |
| EP1921149A1 (en) * | 2006-11-13 | 2008-05-14 | AEterna Zentaris GmbH | Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| MX2009010910A (en) * | 2007-04-12 | 2010-01-20 | Proteosys Ag | Autoimmune regulation of prostate cancer by annexin a3. |
| US7981625B2 (en) | 2008-04-15 | 2011-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Prostate cancer glycan markers and autoantibody signatures |
-
2010
- 2010-03-15 GB GB1004304A patent/GB2478734A/en not_active Withdrawn
-
2011
- 2011-03-11 WO PCT/GB2011/050489 patent/WO2011114139A1/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113721031A (en) * | 2021-08-30 | 2021-11-30 | 河南中医药大学 | Serum-related autoantibody marker for auxiliary diagnosis of hashimoto thyroiditis and application thereof |
| CN113721031B (en) * | 2021-08-30 | 2024-02-13 | 河南中医药大学 | Serum-related autoantibody marker for assisting diagnosis of hashimoto thyroiditis and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2478734A (en) | 2011-09-21 |
| WO2011114139A1 (en) | 2011-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2718721A4 (en) | Circulating biomarkers for cancer | |
| IL229319A0 (en) | Biomarkers for lung cancer | |
| PL2576837T3 (en) | Prostate cancer associated circulating nucleic acid biomarkers | |
| SG2014007454A (en) | Pancreatic cancer biomarkers and uses thereof | |
| EP2625292A4 (en) | CANCER BIOMARKERS | |
| WO2011163332A9 (en) | Methods for detecting cancer | |
| GB201016139D0 (en) | Cancer phosholipidome | |
| PL2931922T3 (en) | Personalized biomarkers for cancer | |
| EP2550631A4 (en) | Mobile payments | |
| WO2012012225A9 (en) | Predicting cancer outcome | |
| GB201012590D0 (en) | Methods for diagnosing cancer | |
| GB201021502D0 (en) | Biomarkers | |
| EP2831270B8 (en) | Biomarker for bladder cancer | |
| GB201008340D0 (en) | Biomarkers | |
| ZA201703026B (en) | Biomarkers for the prediction of incident cancer | |
| GB201018056D0 (en) | Biomarkers | |
| WO2012167112A9 (en) | Gastric cancer biomarkers | |
| EP2707721A4 (en) | Predictive biomarkers for prostate cancer | |
| GB201004442D0 (en) | Biomarker | |
| GB201005561D0 (en) | Biomarkers | |
| GB201001444D0 (en) | Biomarkers | |
| GB2510539B (en) | Biomarkers of cancer | |
| EP2753716A4 (en) | Novel risk biomarkers for lung cancer | |
| EP2501845A4 (en) | Biomarkers of cancer | |
| GB201010316D0 (en) | Biomarkers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |